A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

(2010) Gabriel Sica et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Morphometric Profiling of Lung Cancers—Its Association With Clinicopathologic, Biologic, and Molecular Genetic Features

(2010) Koji Okudela et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Nuclear grading of primary pulmonary adenocarcinomas

(2010) Yoshimasa Nakazato et al.   CANCER

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer

(2010) Enriqueta Felip et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?

(2010) J. Subramanian et al.   JNCI-Journal of the National Cancer Institute

Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study

(2010) Christopher M. Bryant et al.   PLoS One

Prognostic significance of grading in lung adenocarcinoma

(2009) Justine A. Barletta et al.   CANCER

Histological grading of invasive breast carcinoma – a simplification of existing methods in a large conservation series with long-term follow-up

(2009) Jeremy St J Thomas et al.   HISTOPATHOLOGY

Core classification of lung cancer: Correlating nuclear size and mitoses with ploidy and clinicopathological parameters

(2009) Iver Petersen et al.   LUNG CANCER

Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

(2008) Noriko Motoi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

(2008) Gary M. Strauss et al.   JOURNAL OF CLINICAL ONCOLOGY